{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:41:15Z","timestamp":1791855675397,"version":"4.3.4"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.neuroscience.2020.11.034","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T11:13:16Z","timestamp":1606475596000},"page":"140-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Neuronal and Endothelial Transglutaminase-2 Expression during Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis"],"prefix":"10.1016","volume":"461","author":[{"given":"Damien D.","family":"Pearse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Anthony","family":"Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousumi","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2020.11.034_b0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12079-016-0352-8","article-title":"VEGF-A\/VEGFR2 signaling network in endothelial cells relevant to angiogenesis","volume":"10","author":"Abhinand","year":"2016","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0010","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1083\/jcb.148.4.825","article-title":"Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin","volume":"148","author":"Akimov","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0015","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1523\/JNEUROSCI.3353-11.2012","article-title":"Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation","volume":"32","author":"Basso","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1471-4159.2006.04140.x","article-title":"Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders","volume":"100","author":"Battaglia","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0025","article-title":"Induction and clinical scoring of chronic-relapsing experimental autoimmune encephalomyelitis","volume":"224","author":"Beeton","year":"2007","journal-title":"J Vis Exp"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0030","doi-asserted-by":"crossref","first-page":"19683","DOI":"10.1073\/pnas.0609283103","article-title":"Mechanism of allosteric regulation of transglutaminase 2 by GTP","volume":"103","author":"Begg","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0035","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1111\/j.1742-4658.2011.08346.x","article-title":"Extracellular TG2: emerging functions and regulation","volume":"278","author":"Belkin","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0040","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1096\/fj.01-0689com","article-title":"Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient","volume":"16","author":"Bernassola","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-510X(02)00069-2","article-title":"Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease","volume":"206","author":"Bjartmar","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.brainres.2015.08.031","article-title":"How microglia kill neurons","volume":"1628","author":"Brown","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00726-011-1083-z","article-title":"Transglutaminase 2 interaction with small heat shock proteins mediate cell survival upon excitotoxic stress","volume":"44","author":"Caccamo","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0060","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00726-009-0428-3","article-title":"Critical role of transglutaminase and other stress proteins during neurodegenerative processes","volume":"38","author":"Caccamo","year":"2010","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0065","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00726-011-1018-8","article-title":"Monitoring of transglutaminase2 under different oxidative stress conditions","volume":"42","author":"Caccamo","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","article-title":"ERK and cell death: mechanisms of ERK-induced cell death\u2013apoptosis, autophagy and senescence","volume":"277","author":"Cagnol","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0075","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/febs.13276","article-title":"Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies","volume":"282","author":"Cardoso","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0080","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3858\/emm.2010.42.9.063","article-title":"Transglutaminase 2 inhibits apoptosis induced by calciumoverload through down-regulation of Bax","volume":"42","author":"Cho","year":"2010","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0085","article-title":"Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis","volume":"13","author":"Chrobok","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0090","doi-asserted-by":"crossref","first-page":"17180","DOI":"10.1016\/S0021-9258(17)44886-1","article-title":"A novel transglutaminase-mediated post-translational modification of phospholipase A2 dramatically increases its catalytic activity","volume":"265","author":"Cordella-Miele","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines7010014","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis","volume":"7","author":"Correale","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00726-013-1569-y","article-title":"Transglutaminase 2 and phospholipase A2 interactions in the inflammatory response in human Thp-1 monocytes","volume":"46","author":"Curr\u00f2","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0105","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.4161\/auto.5.8.10040","article-title":"Transglutaminase 2 is involved in autophagosome maturation","volume":"5","author":"D'Eletto","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0110","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/cdd.2012.2","article-title":"Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins","volume":"19","author":"D'Eletto","year":"2012","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fneur.2014.00251","article-title":"Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients","volume":"5","author":"David","year":"2014","journal-title":"Front Neurol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0120","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2174\/187152708786441821","article-title":"Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases","volume":"7","author":"De Vivo","year":"2008","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0125","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis \u2013 a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.09.005","article-title":"Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis","volume":"93","author":"Dutta","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100574","article-title":"Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter","volume":"9","author":"Espitia Pinzon","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fncel.2019.00281","article-title":"Tissue transglutaminase promotes early differentiation of oligodendrocyte progenitor cells","volume":"13","author":"Espitia Pinzon","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"10.1016\/j.neuroscience.2020.11.034_b0150","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.4049\/jimmunol.174.11.7330","article-title":"Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment","volume":"174","author":"Falasca","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0155","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1016\/j.febslet.2005.03.063","article-title":"Transglutaminase 2 in the balance of cell death and survival","volume":"579","author":"Fesus","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-60327-017-5_14","article-title":"Regulation of apoptosis by the unfolded protein response","volume":"559","author":"Fribley","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2014.37","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis","volume":"10","author":"Friese","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0170","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2015.06.049","article-title":"Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis","volume":"602","author":"Fuhrmann","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0175","doi-asserted-by":"crossref","first-page":"30707","DOI":"10.1074\/jbc.274.43.30707","article-title":"Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain","volume":"274","author":"Gaudry","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-015-0463-9","article-title":"Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines","volume":"13","author":"Ghosh","year":"2016","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0185","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"P T"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbamcr.2011.09.012","article-title":"Transglutaminase 2: a molecular Swiss army knife","volume":"1823","author":"Gundemir","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0195","doi-asserted-by":"crossref","first-page":"E3966","DOI":"10.1073\/pnas.1409730111","article-title":"Aberrant calcium signaling by transglutaminase-mediated posttranslational modification of inositol 1,4,5-trisphosphate receptors","volume":"111","author":"Hamada","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0200","doi-asserted-by":"crossref","first-page":"32220","DOI":"10.1074\/jbc.M111.255562","article-title":"Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA","volume":"286","author":"Hoffmann","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/187152710791012107","article-title":"Transglutaminase-catalyzed crosslinking in neurological disease: from experimental evidence to therapeutic inhibition","volume":"9","author":"Hoffner","year":"2010","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00726-014-1864-2","article-title":"Transglutaminase 2 and neuroinflammation","volume":"47","author":"Ientile","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0215","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2217\/fnl.09.17","article-title":"Transglutaminase activation in neurodegenerative diseases","volume":"4","author":"Jeitner","year":"2009","journal-title":"Future Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2020.11.034_b0220","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1471-4159.2009.05843.x","article-title":"Transglutaminases and neurodegeneration","volume":"109","author":"Jeitner","year":"2009","journal-title":"J Neurochem"},{"issue":"Pt 5","key":"10.1016\/j.neuroscience.2020.11.034_b0225","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/brain\/113.5.1477","article-title":"Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications","volume":"113","author":"Kermode","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0230","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.2741\/2030","article-title":"Transglutaminase 2 in inflammation","volume":"11","author":"Kim","year":"2006","journal-title":"Front Biosci"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0235","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1083\/jcb.121.2.439","article-title":"Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells","volume":"121","author":"Kojima","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0240","doi-asserted-by":"crossref","first-page":"12655","DOI":"10.1096\/fj.201901358RR","article-title":"The vicious cycle between transglutaminase 2 and reactive oxygen species in hyperglycemic memory-induced endothelial dysfunction","volume":"33","author":"Lee","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0245","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0006-291X(03)00835-0","article-title":"Activation of in situ tissue transglutaminase by intracellular reactive oxygen species","volume":"305","author":"Lee","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0250","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0255","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/cdd.2009.100","article-title":"The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis","volume":"16","author":"Malorni","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0260","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/138161208783413220","article-title":"Type 2 transglutaminase in neurodegenerative diseases: the mitochondrial connection","volume":"14","author":"Malorni","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0265","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.bbabio.2006.07.007","article-title":"\u201cTissue\u201d transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes","volume":"1757","author":"Mastroberardino","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0270","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2796.2010.02275.x","article-title":"Type 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential","volume":"268","author":"Mastroberardino","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0275","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/j.lpm.2015.02.008","article-title":"Update on treatments in multiple sclerosis","volume":"44","author":"Michel","year":"2015","journal-title":"Presse Med"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0280","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2005.11.071","article-title":"The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity","volume":"339","author":"Mishra","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0285","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1074\/jbc.M506864200","article-title":"Phosphorylation of histones by tissue transglutaminase","volume":"281","author":"Mishra","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0290","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbamcr.2014.09.020","article-title":"Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells","volume":"1853","author":"Nadella","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-394305-7.00001-X","article-title":"Cellular functions of tissue transglutaminase","volume":"294","author":"Nurminskaya","year":"2012","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/714561","article-title":"Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family","volume":"2014","author":"Odii","year":"2014","journal-title":"Sci World J"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0305","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clim.2012.08.009","article-title":"Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation","volume":"145","author":"Oh","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0310","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jnc.12441","article-title":"Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1","volume":"128","author":"Oono","year":"2014","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0315","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.arcmed.2014.11.013","article-title":"Role of the blood-brain barrier in multiple sclerosis","volume":"45","author":"Ortiz","year":"2014","journal-title":"Arch Med Res"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0320","doi-asserted-by":"crossref","first-page":"12370","DOI":"10.1038\/s41598-018-30172-8","article-title":"Mechanistic role of transglutaminase-2 in focal adhesions","volume":"8","author":"Png","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0325","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4161\/cam.26344","article-title":"Transglutaminase-2 in cell adhesion: all roads lead to paxillin?","volume":"7","author":"Png","year":"2013","journal-title":"Cell Adhes Migr"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0330","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","article-title":"Emerging roles of caspase-3 in apoptosis","volume":"6","author":"Porter","year":"1999","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0335","doi-asserted-by":"crossref","first-page":"099","DOI":"10.1055\/s-0038-1647261","article-title":"The role of platelet-activating factor in endothelial cells","volume":"64","author":"Prescott","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0340","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jnen\/61.10.914","article-title":"Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats","volume":"61","author":"Proescholdt","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0345","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0350","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/cdd.2014.106","article-title":"Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis","volume":"22","author":"Rossin","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0355","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s00726-011-0899-x","article-title":"TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy","volume":"42","author":"Rossin","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0360","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00726-008-0130-x","article-title":"Some lessons from the tissue transglutaminase knockout mouse","volume":"36","author":"Sarang","year":"2009","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0365","doi-asserted-by":"crossref","first-page":"13128","DOI":"10.1074\/jbc.M809067200","article-title":"Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of alpha-synuclein: implications for the pathogenesis of Parkinson disease","volume":"284","author":"Schmid","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0370","first-page":"165","article-title":"Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues","volume":"148","author":"Schweitzer","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0375","doi-asserted-by":"crossref","first-page":"35532","DOI":"10.1074\/jbc.M807656200","article-title":"Caspase-mediated Bak activation and cytochrome c release during intrinsic apoptotic cell death in Jurkat cells","volume":"283","author":"Shawgo","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0380","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharmthera.2007.05.003","article-title":"Transglutaminase 2 inhibitors and their therapeutic role in disease states","volume":"115","author":"Siegel","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0385","article-title":"Transglutaminases in Monocytes and Macrophages","volume":"6","author":"Sun","year":"2018","journal-title":"Med Sci (Basel)"},{"issue":"10","key":"10.1016\/j.neuroscience.2020.11.034_b0390","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/sj.cdd.4401889","article-title":"Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia\/reperfusion injury by regulating ATP synthesis","volume":"13","author":"Szondy","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0395","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1073\/pnas.0832466100","article-title":"Transglutaminase 2-\/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells","volume":"100","author":"Szondy","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0400","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.4049\/jimmunol.0803444","article-title":"Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells","volume":"182","author":"Toth","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0405","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/bi00428a032","article-title":"Complexation of fibronectin with tissue transglutaminase","volume":"28","author":"Turner","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0410","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/glia.21204","article-title":"Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination","volume":"59","author":"Van Strien","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025037","article-title":"Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?","volume":"6","author":"van Strien","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2015.06.023","article-title":"Tissue transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration","author":"van Strien","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0425","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1750-3639.2010.00428.x","article-title":"Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?","volume":"21","author":"van Strien","year":"2011","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0430","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.318","article-title":"A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis","volume":"4","author":"Wang","year":"2013","journal-title":"Cell Death Dis"},{"issue":"Suppl 3","key":"10.1016\/j.neuroscience.2020.11.034_b0435","doi-asserted-by":"crossref","first-page":"S289","DOI":"10.3233\/JAD-132492","article-title":"Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target","volume":"42","author":"Wilhelmus","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0440","doi-asserted-by":"crossref","first-page":"20569","DOI":"10.1038\/srep20569","article-title":"Catalytically active tissue transglutaminase colocalises with Abeta pathology in Alzheimer's disease mouse models","volume":"6","author":"Wilhelmus","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0445","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejphar.2008.01.059","article-title":"Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases","volume":"585","author":"Wilhelmus","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0450","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.mayocp.2013.11.002","article-title":"Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies","volume":"89","author":"Wingerchuk","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0455","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ncl.2010.12.009","article-title":"The immunopathophysiology of multiple sclerosis","volume":"29","author":"Wu","year":"2011","journal-title":"Neurol Clin"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0460","doi-asserted-by":"crossref","first-page":"14377","DOI":"10.1074\/jbc.M111.326074","article-title":"Transglutaminase 2 promotes both caspase-dependent and caspase-independent apoptotic cell death via the calpain\/Bax protein signaling pathway","volume":"287","author":"Yoo","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0465","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/sj.onc.1210048","article-title":"Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy","volume":"26","author":"Yuan","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0470","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/WNR.0000000000000895","article-title":"Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia","volume":"28","author":"Yunes-Medina","year":"2017","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuroscience.2020.11.034_b0475","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2741\/1863","article-title":"The role of tissue transglutaminase in cell-matrix interactions","volume":"11","author":"Zemskov","year":"2006","journal-title":"Front Biosci"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452220307569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452220307569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:04:56Z","timestamp":1759680296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452220307569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":95,"alternative-id":["S0306452220307569"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2020.11.034","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal and Endothelial Transglutaminase-2 Expression during Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2020.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of IBRO.","name":"copyright","label":"Copyright"}]}}